 |
 |
|
 |
|
Accession |
Disease |
Description |
Year |
Source |
RNA-Seq |
Count |
Biomarkers |
|
GSE122497 |
Esophageal Cancer |
Large-scale serum microRNA profiling for developing an esophageal squamous cell carcinoma detection model |
2018 |
Serum |
N |
5531 |
 |
|
GSE53625 |
Esophageal Cancer |
LncRNA profile study reveals a three-lncRNA signature associated with the survival of esophageal squamous cell carcinoma patients |
2013 |
Tissue |
N |
358 |
|
|
GSE55856 |
Esophageal Cancer |
Comprehensive Analysis of Recurrence-Associated Small Non-Coding RNAs in Esophageal Cancer |
2014 |
Tissue |
N |
216 |
|
|
GSE164174 |
Gastric Cancer |
A novel combination of serum microRNAs for the detection of early gastric cancer |
2021 |
Serum |
N |
2934 |
|
|
GSE121870 |
Gastric Cancer |
dentifying novel small RNA biomarkers unique to patients with gastric cancer |
2018 |
Saliva |
N |
198 |
|
|
GSE30070 |
Gastric Cancer |
Gastric cancer: cancer vs. normal, chemoresistance signature that correlates with time to progression of disease |
2011 |
Tissue |
N |
132 |
|
|
GSE26595 |
Gastric Cancer |
MicroRNA expression of primary gastric adenocarcinoma compared to non-cancer gastric tissue |
2011 |
Tissue |
N |
68 |
|
|
GSE78775 |
Gastric Cancer |
MiR-148a Functions as a Tumor Suppressor by Targeting CCK-BR via Inactivating STAT3 and Akt in Human Gastric Cancer |
2016 |
Tissue |
N |
56 |
 |
|
GSE78049 |
Gastric Cancer |
Clinical impact of a novel microRNA chemo-sensitivity predictor in gastroesophageal cancer |
2016 |
Tissue |
N |
53 |
|
|
GSE63453 |
Gastric Cancer |
Differences of miRNA expression profiling between GIST and leiomyoma tissue samples acquired by Tunneling Bloc Biopsy |
2014 |
Tissue |
N |
16 |
|
|
GSE113956 |
Oral Cancer |
Serum miRNA expression in 25 oral squamous cell cancer patients with different five years survival status and 15 healthy controls |
2018 |
Serum |
N |
40 |
|
|
|
|
|
|
|
|
|